To test the neuroendocrine response in 48 obsessive-compulsive patients aged 16-45 to low dose (12.5 mg) parenteral CMI. Also to determine the acute efficacy of high dose (200mg) bolus CMI vs. placebo saline to relieve OCD.
Showing the most recent 10 out of 395 publications